Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Oth

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	175 Pages	Coherent Market Insights	July, 2024	CMI19325130

Best Price Guarantee
Price	from $4,500
Length	175 Pages
Publisher	Coherent Market Insights
Published Date	July, 2024
SKU	CMI19325130

Table of Contents
Description

Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Cancer therapeutics and biotherapeutics is a large and growing market globally. While conventional treatment options such as chemotherapy have limitations, newer biological and targeted therapies are revolutionizing cancer treatment. Biological therapies harness the power of the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal and cancerous cells. With advances in understanding cancer biology and technological innovations, a wide range of biologics and targeted therapies are being developed and commercialized. These newer therapeutic approaches have improved survival and quality of life for many cancer patients.

Market Dynamics:

The global cancer therapeutics and biotherapeutics market growth is driven by the rising global cancer burden, growing demand for personalized medicine, increasing research funding for cancer drug development, and launch of novel targeted and biological therapies. However, high developmental costs of biologics and targeted drugs along with associated technical challenges are restraining the market growth. Ongoing R&D for newer mechanisms and combination therapies provide opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global cancer therapeutics and biotherapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer therapeutics and biotherapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Roche, Novartis, Pfizer, AstraZeneca, GlaxoSmithKline and AbbVie.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer therapeutics and biotherapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapeutics and biotherapeutics market

Detailed Segmentation-

By Application
Blood Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Giloblastoma
Malignant Meningioma
Mesothelioma
Melanoma
Others
By Therapy Type
Chemotherapy
Targeted Therapy
Immunotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Others
By End User
Hospitals & Clinics
Cancer Care Centers
Research Institutes
Others
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Amgen Inc.
Bristol-Myers Squibb
Celgene Corporation
ELI Lilly and Company
Hoffmann-La Roche AG
EnGeneIC Ltd
Merck & Co Inc.
Novartis
Pfizer Inc.
Johnson & Johnson
AstraZeneca
Bristol-Myers Squibb
Biogen IDEC
Sanofi
Novartis AG
Roche
Schering-Plough
Gilead Sciences
Takeda Pharmaceutical Company

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Application; Market Snapshot, By Therapy Type; Market Snapshot, By End Users; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunities; Impact Analysis; Market Trends; Key Developments; Regulatory Scenario; Acquisitions and Partnerships Scenario; Funding and Investments; PEST Analysis; Porter’s Analysis
4. Global Cancer Therapeutics and Biotherapeutics Market - Impact of Coronavirus (COVID-19) Pandemic: Overall Impact; Government Initiatives; COVID-19 Impact on the Market
5. Global Cancer Therapeutics and Biotherapeutics Market, By Application, 2019 – 2031, (USD Bn): Overview; Market Share Analysis, 2024 and 2031 (%); Y-o-Y Growth Analysis, 2020 – 2031; Segment Trends; Blood Cancer; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Lung Cancer; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Colorectal Cancer; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Prostate Cancer; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Cervical Cancer; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Head and Neck Cancer; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Giloblastoma; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Malignant Meningioma; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Mesothelioma; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Melanoma; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Cancer Therapeutics and Biotherapeutics Market, By Therapy Type, 2019 – 2031, (USD Bn): Overview; Market Share Analysis, 2024 and 2031 (%); Y-o-Y Growth Analysis, 2020 – 2031; Segment Trends; Chemotherapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Radiation Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Hormone Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Biotherapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Cancer Therapeutics and Biotherapeutics Market, By End-User, 2019 – 2031, (USD Bn): Overview; Market Share Analysis, 2024 and 2031 (%); Y-o-Y Growth Analysis, 2020 – 2031; Segment Trends; Hospitals & Clinics; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Cancer Care Centers; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Research Institutes; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Cancer Therapeutics and Biotherapeutics Market, By Region, 2019 – 2031, (USD Bn): Introduction; Market Share Analysis, By Region, 2024 and 2031 (%); Y-o-Y Growth Analysis, For Region, 2020–2031; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Clinical Applications, 2019; Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn); North Africa; Central Africa; South Africa
9. Competitive Landscape: Company Profiles; Amgen Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Bristol-Myers Squibb; Celgene Corporation; ELI Lilly and Company; Hoffmann-La Roche AG; EnGeneIC Ltd; Merck & Co Inc.; Novartis; Pfizer Inc.; Johnson & Johnson; AstraZeneca; Bristol-Myers Squibb; Biogen IDEC; Sanofi; Novartis AG; Roche; Schering-Plough; Gilead Sciences; Takeda Pharmaceutical Company
10. Analyst Recommendations: Wheel of Fortune; Analyst View; Coherent Opportunity Map
11. References and Research Methodology: References; Research Methodology; About us and Sales Contact; *Browse 32 market data tables and 28 figures on Cancer Therapeutics and Biotherapeutics Market” - Global forecast to 2031